Why the study?
Do atrial and brain natriuretic peptides serve as objective markers of response to cardiac resynchronisation therapy in patients with drug refractory heart failure?
Population
30 consecutive patients with drug refractory heart failure, mean age 65, 23 men. 13 had ischaemic and 17 had…
Design
Cohort
Authors
Loading...
Reductions in ANP/BNP track clinical CRT response; leaves open their utility as routine objective markers pending prospective validation.
Do atrial and brain natriuretic peptides serve as objective markers of response to cardiac resynchronisation therapy in patients with drug refractory heart failure?
Sander G. Molhoek (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: